Considering these results, it is tempting to speculate that mutant p53 may be a major contributor to the initiation of colitis-associated colorectal cancer, and perhaps in other types of cancers as well, by augmenting the initial inflammatory response into a chronic inflammation, which further contributes to carcinogenesis. Here, TP53 is linked to colitis.